Abstract:Background: Liver is the pivotal organ responsible for plasma protein production, biliary secretion, xenobiotic elimination, glucose and lipid homeostasis. Dysregulation of these functions usually leads to liver diseases and further related complications. The incidence of liver diseases is increasing worldwide, with high morbidity and mortality when at advanced stages, and has become significant public health concern and substential economic burden. Thus, novel therapeutic strategies for managing liver diseases progression are urgently required. T. ruticarpum is one of the most famous and frequently used herbal medicine and has been prescribed in traditional Chinese medicine (TCM) formulas for the treatment of various ailments, including liver diseases. A considerable amount of bioactive ingredients have been isolated and identified from the roots of T. ruticarpum, including alkaloids, saponins, phenols, volatile oils and other compounds. Among these compounds, evodiamine (EVO) and rutaecarpine (RUT) are believed to be the most bioactive compounds. Purpose: To summarize recent findings regarding to the metabolism, pharmacological/toxicological effects of EVO and RUT and to highlight the potential therapeutic effects of them against liver diseases. Methods: Online academic databases (including PubMed, Google Scholar, Web of Science and CNKI) were searched using search terms of "T. ruticarpum", "Wu Zhu Yu", "evodiamine", "rutaecarpine", "liver" and combinations to include published studies of EVO and RUT primarily from 2004-2019. Several critical previous studies beyond this period were also included. Results: Evodiamine (EVO) and rutaecarpine (RUT) are believed to be the most bioactive alkaloids in T. ruticarpum, having anti-inflammation, anti-fibrosis, anti-lipotoxicity, anti-cancer activities, and thus having potential to improve liver disorders. In the current review, we comprehensively summarized recent progresses in the studies of EVO- and RUT-mediated promising hepatoprotective effects and also provide novel insights regarding the potential use of EVO and RUT as therapeutic options for the treatment of liver diseases. Conclusion: With further in-depth pharmacology and pharmacokinetic studies, we believe that natural products in T. ruticarpum and their derivatives will become promising medicines with improved clinical efficacy for the treatment of liver diseases in the immediate future.

Antitumor Activity and Theoretical Calculation of Evodiamine and Rutaecarpine

Synthesis, Antitumor Activity, Oil-Water Partition Coefficient, and Theoretical Calculation of 2 New Rutaecarpine Derivatives With Methoxy Groups

Antiproliferative Activity and Cellular Uptake of Evodiamine and Rutaecarpine Based on 3D Tumor Models

Studied on the antitumor activities of alkaloid from Evodia rutaecarpa

Synthesis and Antitumor Activity of Evodiamine Derivatives with Nitro, Amino, and Methoxy Groups

The Design, Synthesis, and Evaluation of Evodiamine Derivatives with Hydroxy Groups

The Design, Synthesis, and Evaluation of Evodiamine Derivatives with Hydroxyl Groups

Studies on the Chemical Constituents of Evodia Rutaecarpa and Evodia Rutaecarpa Passed with Liquorice and Biological Activities

Design, Synthesis and Biological Evaluation of Novel Evodiamine and Rutaecarpine Derivatives Against Phytopathogenic Fungi.

Alkaloids from the nearly ripe fruits of Evodia rutaecarpa and their bioactivities

Evodiamine: A Novel Anti-Cancer Alkaloid from Evodia Rutaecarpa

Design, synthesis, and biological evaluation of 3,4,5-trimethoxy evodiamine derivatives as potential antitumor agents

Evodiamine: A Extremely Potential Drug Development Candidate of Alkaloids from Evodia rutaecarpa

Synthesis , in vitro and in vivo antitumor activity and docking studies of new evodiamine derivatives

Antitumor Effects of Evodiamine in Mice Model Experiments: A Systematic Review and Meta-Analysis

Research progress on evodiamine, a bioactive alkaloid of Evodiae fructus: Focus on its anti-cancer activity and bioavailability (Review)

Network pharmacology-based strategy to investigate the bioactive ingredients and molecular mechanism of Evodia rutaecarpa in colorectal cancer

Synthesis of 1,2,3,4-Tetrahydroeudistomin U Derivatives and PreliminaryIn Vitro. Antitumor Evaluation

Design, Synthesis and Bioactivity Evaluation of Novel N-phenyl-substituted Evodiamine Derivatives As Potent Anti-Tumor Agents

Evodiamine and Rutaecarpine from Tetradium Ruticarpum in the Treatment of Liver Diseases.

Evodiamine and rutaecarpine from <i>Tetradium ruticarpum</i> in the treatment of liver diseases